RA CAPITAL MANAGEMENT LLC 13D/13G Filings for Concert Pharmaceuticals, Inc. (CNCE)

RA CAPITAL MANAGEMENT LLC 13D and 13G filings for Concert Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-14
4:45 pm
Purchase
2022-12-3113GConcert Pharmaceuticals, Inc.
CNCE
RA CAPITAL MANAGEMENT LLC5,199,746
9.990%
1,689,643increase
(+48.14%)
Filing
2022-02-14
4:11 pm
Purchase
2021-12-3113GConcert Pharmaceuticals, Inc.
CNCE
RA CAPITAL MANAGEMENT LLC3,510,103
9.990%
1,686,583increase
(+92.49%)
Filing
2021-02-16
4:39 pm
Purchase
2020-12-3113GConcert Pharmaceuticals, Inc.
CNCE
RA CAPITAL MANAGEMENT LLC1,823,520
5.900%
1,823,520increase
(New Position)
Filing